• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

建立并验证一个列线图模型以预测甲状腺微小癌的颈部淋巴结转移

Development and validation of a nomogram for preoperative prediction of cervical lymph node involvement in thyroid microcarcinoma.

机构信息

Zhejiang Chinese Medical University Affiliated Hangzhou First Hospital, Hangzhou First People's Hospital, Hangzhou 310006, Zhejiang, China.

Department of Medical Oncology, Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University, Hangzhou 310000, Zhejiang, China.

出版信息

Aging (Albany NY). 2020 Mar 13;12(6):4896-4906. doi: 10.18632/aging.102915.

DOI:10.18632/aging.102915
PMID:32170046
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7138557/
Abstract

Cervical regional lymph node involvement (CRLNI) is common in papillary thyroid microcarcinoma (PTMC), but the way to deal with cervical lymph node involvement of clinically negative PTMC is controversial. We studied data of patients histologically confirmed PTMC in the Surveillance, Epidemiology, and End Results (SEER) Program and Department of Surgical Oncology in Hangzhou First People's Hospital (China). We screened 6 variables of demographic and clinicopathological characteristics as potential predictors and further constructed a lymph node involvement model based on the independent predictors including age, race, sex, extension, multifocality and tumor size. The model was validated by both the internal and the external testing sets, and the visual expression of the model was displayed by a nomogram. As a result, the C-index of this predictive model in the training set was 0.766, and the internal and external testing sets through cross-validation were 0.753 and 0.668, respectively. The area under the receiver operating characteristic curve (AUC) was 0.766 for the training set. We also performed a Decision Curve Analysis (DCA), which showed that predicting the cervical lymph node involvement risk applying this nomogram would be better than having all patients or none patients use this nomogram.

摘要

颈部区域淋巴结受累(CRLNI)在甲状腺微小乳头状癌(PTMC)中很常见,但对于临床阴性的 PTMC 颈部淋巴结受累的处理方式仍存在争议。我们研究了监测、流行病学和最终结果(SEER)计划以及杭州第一人民医院外科肿瘤学系中经组织学证实的 PTMC 患者的数据。我们筛选了 6 个与人口统计学和临床病理特征相关的变量作为潜在预测因子,并进一步构建了一个基于独立预测因子(包括年龄、种族、性别、延伸、多灶性和肿瘤大小)的淋巴结受累模型。该模型通过内部和外部测试集进行了验证,并通过列线图显示了该模型的可视化表达。结果显示,该预测模型在训练集中的 C 指数为 0.766,通过交叉验证在内部和外部测试集中分别为 0.753 和 0.668。训练集的受试者工作特征曲线下面积(AUC)为 0.766。我们还进行了决策曲线分析(DCA),结果表明,应用该列线图预测颈部淋巴结受累风险将优于让所有患者或无患者使用该列线图。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2df0/7138557/eee6953815c2/aging-12-102915-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2df0/7138557/62d666cf37c8/aging-12-102915-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2df0/7138557/7a769fb2124c/aging-12-102915-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2df0/7138557/fa19dd3e6092/aging-12-102915-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2df0/7138557/a982b89ec2b6/aging-12-102915-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2df0/7138557/eee6953815c2/aging-12-102915-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2df0/7138557/62d666cf37c8/aging-12-102915-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2df0/7138557/7a769fb2124c/aging-12-102915-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2df0/7138557/fa19dd3e6092/aging-12-102915-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2df0/7138557/a982b89ec2b6/aging-12-102915-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2df0/7138557/eee6953815c2/aging-12-102915-g005.jpg

相似文献

1
Development and validation of a nomogram for preoperative prediction of cervical lymph node involvement in thyroid microcarcinoma.建立并验证一个列线图模型以预测甲状腺微小癌的颈部淋巴结转移
Aging (Albany NY). 2020 Mar 13;12(6):4896-4906. doi: 10.18632/aging.102915.
2
Nomogram for Preoperative Estimation of Cervical Lymph Node Metastasis Risk in Papillary Thyroid Microcarcinoma.甲状腺微小乳头状癌颈淋巴结转移风险术前预测列线图
Front Endocrinol (Lausanne). 2021 Mar 31;12:613974. doi: 10.3389/fendo.2021.613974. eCollection 2021.
3
Development of a nomogram for prediction of central lymph node metastasis of papillary thyroid microcarcinoma.建立预测甲状腺微小乳头状癌中央区淋巴结转移的列线图。
BMC Cancer. 2024 Feb 20;24(1):235. doi: 10.1186/s12885-024-12004-3.
4
Web-Based Ultrasonic Nomogram Predicts Preoperative Central Lymph Node Metastasis of cN0 Papillary Thyroid Microcarcinoma.基于网络的超声列线图预测 cN0 期甲状腺微小乳头状癌的术前中央区淋巴结转移。
Front Endocrinol (Lausanne). 2021 Sep 7;12:734900. doi: 10.3389/fendo.2021.734900. eCollection 2021.
5
Construction and validation of a nomogram for predicting cervical lymph node metastasis in classic papillary thyroid carcinoma.构建并验证经典型甲状腺乳头状癌颈淋巴结转移预测列线图。
J Endocrinol Invest. 2021 Oct;44(10):2203-2211. doi: 10.1007/s40618-021-01524-5. Epub 2021 Feb 14.
6
Development and Validation of a Computed Tomography-Based Radiomics Nomogram for the Preoperative Prediction of Central Lymph Node Metastasis in Papillary Thyroid Microcarcinoma.基于计算机断层扫描的影像组学列线图模型预测甲状腺微小乳头状癌中央区淋巴结转移的建立与验证
Acad Radiol. 2024 May;31(5):1805-1817. doi: 10.1016/j.acra.2023.11.030. Epub 2023 Dec 9.
7
Papillary Thyroid Microcarcinoma: A Nomogram Based on Clinical and Ultrasound Features to Improve the Prediction of Lymph Node Metastases in the Central Compartment.甲状腺微小乳头状癌:基于临床和超声特征的列线图,以提高中央区淋巴结转移的预测准确性。
Front Endocrinol (Lausanne). 2022 Jan 12;12:770824. doi: 10.3389/fendo.2021.770824. eCollection 2021.
8
Development and validation of an individualized nomogram for predicting the high-volume (> 5) central lymph node metastasis in papillary thyroid microcarcinoma.开发和验证用于预测甲状腺微小乳头状癌中高容量(>5)中央淋巴结转移的个体化列线图。
J Endocrinol Invest. 2022 Mar;45(3):507-515. doi: 10.1007/s40618-021-01675-5. Epub 2021 Sep 7.
9
Nomogram for predicting central lymph node metastasis in papillary thyroid microcarcinoma: A retrospective cohort study of 8668 patients.预测甲状腺微小乳头状癌中央区淋巴结转移的列线图:一项回顾性队列研究,纳入 8668 例患者。
Int J Surg. 2018 Jul;55:98-102. doi: 10.1016/j.ijsu.2018.05.023. Epub 2018 May 25.
10
Treatment strategies and predicting lymph node metastasis in elderly patients with papillary thyroid microcarcinoma.老年甲状腺微小乳头状癌患者的治疗策略及淋巴结转移预测
Medicine (Baltimore). 2021 May 7;100(18):e25811. doi: 10.1097/MD.0000000000025811.

引用本文的文献

1
A CT based radiomics analysis to predict the CN0 status of thyroid papillary carcinoma: a two- center study.基于 CT 的放射组学分析预测甲状腺乳头状癌的 CN0 状态:一项双中心研究。
Cancer Imaging. 2024 May 15;24(1):62. doi: 10.1186/s40644-024-00690-y.
2
Development of a nomogram for prediction of central lymph node metastasis of papillary thyroid microcarcinoma.建立预测甲状腺微小乳头状癌中央区淋巴结转移的列线图。
BMC Cancer. 2024 Feb 20;24(1):235. doi: 10.1186/s12885-024-12004-3.
3
An integrated nomogram combining deep learning, clinical characteristics and ultrasound features for predicting central lymph node metastasis in papillary thyroid cancer: A multicenter study.

本文引用的文献

1
Radiomic analysis for preoperative prediction of cervical lymph node metastasis in patients with papillary thyroid carcinoma.基于影像组学的术前预测甲状腺乳头状癌颈淋巴结转移的研究
Eur J Radiol. 2019 Sep;118:231-238. doi: 10.1016/j.ejrad.2019.07.018. Epub 2019 Jul 19.
2
Individual prediction of lateral neck metastasis risk in patients with unifocal papillary thyroid carcinoma.单发甲状腺乳头状癌患者侧颈部淋巴结转移风险的个体预测。
Eur J Surg Oncol. 2019 Jun;45(6):1039-1045. doi: 10.1016/j.ejso.2019.02.016. Epub 2019 Feb 21.
3
Nomogram for predicting level V lymph node metastases in papillary thyroid carcinoma with clinically lateral lymph node metastases: A large retrospective cohort study of 1037 patients from FDUSCC.
基于深度学习、临床特征和超声特征的综合列线图预测甲状腺乳头状癌中央区淋巴结转移:一项多中心研究。
Front Endocrinol (Lausanne). 2023 Feb 21;14:964074. doi: 10.3389/fendo.2023.964074. eCollection 2023.
4
A modified survival model for patients with esophageal squamous cell carcinoma based on lymph nodes: A study based on SEER database and external validation.基于淋巴结的食管鳞状细胞癌患者改良生存模型:一项基于监测、流行病学和最终结果(SEER)数据库及外部验证的研究
Front Surg. 2022 Sep 7;9:989408. doi: 10.3389/fsurg.2022.989408. eCollection 2022.
5
Development of an Active Surveillance or Surgery Model to Predict Lymph Node Metastasis in cN0 Papillary Thyroid Microcarcinoma.开发一种主动监测或手术模型,以预测 cN0 期甲状腺微小乳头状癌的淋巴结转移。
Front Endocrinol (Lausanne). 2022 Jul 22;13:896121. doi: 10.3389/fendo.2022.896121. eCollection 2022.
6
Male Gender Is Associated with Lymph Node Metastasis but Not with Recurrence in Papillary Thyroid Carcinoma.男性与甲状腺乳头状癌的淋巴结转移相关,但与复发无关。
Int J Endocrinol. 2022 Feb 28;2022:3534783. doi: 10.1155/2022/3534783. eCollection 2022.
7
Extranodal Extension Is an Independent Prognostic Factor in Papillary Thyroid Cancer: A Propensity Score Matching Analysis.结外侵犯是甲状腺乳头状癌的独立预后因素:倾向评分匹配分析。
Front Endocrinol (Lausanne). 2021 Nov 3;12:759049. doi: 10.3389/fendo.2021.759049. eCollection 2021.
8
Describing Treatment Patterns for Elderly Patients with Intrahepatic Cholangiocarcinoma and Predicting Prognosis by a Validated Model: A Population-Based Study.描述肝内胆管癌老年患者的治疗模式并通过验证模型预测预后:一项基于人群的研究
J Cancer. 2021 Mar 30;12(11):3114-3125. doi: 10.7150/jca.53978. eCollection 2021.
9
Application of Machine Learning Algorithms to Predict Central Lymph Node Metastasis in T1-T2, Non-invasive, and Clinically Node Negative Papillary Thyroid Carcinoma.应用机器学习算法预测T1-T2期、非侵袭性且临床淋巴结阴性的乳头状甲状腺癌的中央淋巴结转移
Front Med (Lausanne). 2021 Mar 9;8:635771. doi: 10.3389/fmed.2021.635771. eCollection 2021.
10
Predicting non-small-volume central lymph node metastases (>5 or ≥2 mm) preoperatively in cN0 papillary thyroid microcarcinoma without extrathyroidal extension.术前预测无甲状腺外侵犯的cN0期甲状腺微小乳头状癌的非小体积中央区淋巴结转移(>5或≥2mm)
Medicine (Baltimore). 2020 Sep 18;99(38):e22338. doi: 10.1097/MD.0000000000022338.
预测伴有临床侧方淋巴结转移的甲状腺乳头状癌Ⅴ区淋巴结转移的列线图:一项来自FDUSCC的1037例患者的大型回顾性队列研究
J Cancer. 2019 Jan 1;10(3):772-778. doi: 10.7150/jca.28527. eCollection 2019.
4
Prediction of central lymph node metastasis in papillary thyroid microcarcinoma according to clinicopathologic factors and thyroid nodule sonographic features: a case-control study.根据临床病理因素和甲状腺结节超声特征预测甲状腺微小乳头状癌中央淋巴结转移:一项病例对照研究
Cancer Manag Res. 2018 Sep 4;10:3237-3243. doi: 10.2147/CMAR.S169741. eCollection 2018.
5
Multifocality is associated with central neck lymph node metastases in papillary thyroid microcarcinoma.多灶性与甲状腺微小乳头状癌的中央区颈部淋巴结转移相关。
Cancer Manag Res. 2018 Jun 14;10:1527-1533. doi: 10.2147/CMAR.S163263. eCollection 2018.
6
Nomogram for predicting central lymph node metastasis in papillary thyroid microcarcinoma: A retrospective cohort study of 8668 patients.预测甲状腺微小乳头状癌中央区淋巴结转移的列线图:一项回顾性队列研究,纳入 8668 例患者。
Int J Surg. 2018 Jul;55:98-102. doi: 10.1016/j.ijsu.2018.05.023. Epub 2018 May 25.
7
Survival prediction in mesothelioma using a scalable Lasso regression model: instructions for use and initial performance using clinical predictors.使用可扩展套索回归模型预测间皮瘤生存率:使用临床预测指标的使用说明和初始性能
BMJ Open Respir Res. 2018 Jan 30;5(1):e000240. doi: 10.1136/bmjresp-2017-000240. eCollection 2018.
8
A Nomogram Based on the Characteristics of Metastatic Lymph Nodes to Predict Papillary Thyroid Carcinoma Recurrence.基于转移淋巴结特征的列线图预测甲状腺乳头状癌复发。
Thyroid. 2018 Mar;28(3):301-310. doi: 10.1089/thy.2017.0422.
9
Differentiated and anaplastic thyroid carcinoma: Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual.分化型和间变性甲状腺癌:美国癌症联合委员会第八版癌症分期手册的重大变化。
CA Cancer J Clin. 2018 Jan;68(1):55-63. doi: 10.3322/caac.21439. Epub 2017 Nov 1.
10
The STROCSS statement: Strengthening the Reporting of Cohort Studies in Surgery.STROCSS 声明:加强外科学队列研究报告。
Int J Surg. 2017 Oct;46:198-202. doi: 10.1016/j.ijsu.2017.08.586. Epub 2017 Sep 7.